184 related articles for article (PubMed ID: 12754511)
21. Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors.
Fujiwara K; Yuwanita I; Hollern DP; Andrechek ER
Cancer Res; 2011 Mar; 71(5):1924-32. PubMed ID: 21245101
[TBL] [Abstract][Full Text] [Related]
22. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
23. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
24. Transgenic oncogene mice. Tumor phenotype predicts genotype.
Cardiff RD; Sinn E; Muller W; Leder P
Am J Pathol; 1991 Sep; 139(3):495-501. PubMed ID: 1887859
[TBL] [Abstract][Full Text] [Related]
25. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
[TBL] [Abstract][Full Text] [Related]
27. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway.
Young AP; Nagarajan R; Longmore GD
Oncogene; 2003 Oct; 22(46):7209-17. PubMed ID: 14562049
[TBL] [Abstract][Full Text] [Related]
29. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
[TBL] [Abstract][Full Text] [Related]
30. c-Myc-regulated microRNAs modulate E2F1 expression.
O'Donnell KA; Wentzel EA; Zeller KI; Dang CV; Mendell JT
Nature; 2005 Jun; 435(7043):839-43. PubMed ID: 15944709
[TBL] [Abstract][Full Text] [Related]
31. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F.
Montigiani S; Müller R; Kontermann RE
Oncogene; 2003 Aug; 22(32):4943-52. PubMed ID: 12902977
[TBL] [Abstract][Full Text] [Related]
33. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
34. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
36. Neuregulin-regulated gene expression in mammary carcinoma cells.
Amin DN; Tuck D; Stern DF
Exp Cell Res; 2005 Sep; 309(1):12-23. PubMed ID: 15963498
[TBL] [Abstract][Full Text] [Related]
37. Genes and genetic networks responsive to mild hyperthermia in human lymphoma U937 cells.
Tabuchi Y; Takasaki I; Wada S; Zhao QL; Hori T; Nomura T; Ohtsuka K; Kondo T
Int J Hyperthermia; 2008 Dec; 24(8):613-22. PubMed ID: 18608577
[TBL] [Abstract][Full Text] [Related]
38. Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors.
Polanowska J; Le Cam L; Orsetti B; Vallés H; Fabbrizio E; Fajas L; Taviaux S; Theillet C; Sardet C
Genes Chromosomes Cancer; 2000 May; 28(1):126-30. PubMed ID: 10738311
[TBL] [Abstract][Full Text] [Related]
39. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568
[TBL] [Abstract][Full Text] [Related]
40. "Sub-threshold neoplastic states" created in transgenic mice.
Rassoulzadegan M; Cuzin F
Oncogene Res; 1987 Jun; 1(1):1-6. PubMed ID: 2835726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
